Search research articles
Contact Us
Filters
Showing results (371-380 of 434) with videos related to
Page
of 44
Sort By:
Prostate Cancer and Prostatic Diseases
|
October 1, 2020
Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology
Bastiaan M Privé, Bas Israël, Melline G M Schilham, et al.
Cancer Treatment and Research Communications
|
April 14, 2022
Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands
Désirée van Deukeren, Berdine L Heesterman, Lianne Roelofs, et al.
BJU International
|
May 22, 2025
A study of oral metformin for the intravesical treatment of non-muscle-invasive bladder cancer
Jons W van Hattum, Marinka J Remmelink, Sieb T Nuijens, et al.
European Urology
|
May 15, 2018
Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)
Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al.
Oncotarget
|
January 12, 2017
A short-term intervention with selenium affects expression of genes implicated in the epithelial-to-mesenchymal transition in the prostate
Dieuwertje E G Kok, Lambertus A L M Kiemeney, Gerald W Verhaegh, et al.
European Urology Oncology
|
December 24, 2019
The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel
Harman M Bruins, Erik Veskimäe, Virginia Hernández, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial
Cora N Sternberg, Daniel P Petrylak, Oliver Sartor, et al.
European Urology
|
December 27, 2021
International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin-exposed High-risk Non-muscle-invasive Bladder Cancer
Mathieu Roumiguié, Ashish M Kamat, Trinity J Bivalacqua, et al.
European Urology Open Science
|
May 9, 2022
Learning Curve Analysis for Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section Scientific Working Group
Carl J Wijburg, Gerjon Hannink, Charlotte T J Michels, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 19, 2006
IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI
Emile N J T van Lin, Jurgen J Fütterer, Stijn W T P J Heijmink, et al.
Page
of 44
Search research articles
Search
Showing results (371-380 of 434) with videos related to
Sort By:
Page
of 44
Prostate Cancer and Prostatic Diseases
|
October 1, 2020
Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology
Bastiaan M Privé, Bas Israël, Melline G M Schilham, et al.
Cancer Treatment and Research Communications
|
April 14, 2022
Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands
Désirée van Deukeren, Berdine L Heesterman, Lianne Roelofs, et al.
BJU International
|
May 22, 2025
A study of oral metformin for the intravesical treatment of non-muscle-invasive bladder cancer
Jons W van Hattum, Marinka J Remmelink, Sieb T Nuijens, et al.
European Urology
|
May 15, 2018
Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)
Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al.
Oncotarget
|
January 12, 2017
A short-term intervention with selenium affects expression of genes implicated in the epithelial-to-mesenchymal transition in the prostate
Dieuwertje E G Kok, Lambertus A L M Kiemeney, Gerald W Verhaegh, et al.
European Urology Oncology
|
December 24, 2019
The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel
Harman M Bruins, Erik Veskimäe, Virginia Hernández, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial
Cora N Sternberg, Daniel P Petrylak, Oliver Sartor, et al.
European Urology
|
December 27, 2021
International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin-exposed High-risk Non-muscle-invasive Bladder Cancer
Mathieu Roumiguié, Ashish M Kamat, Trinity J Bivalacqua, et al.
European Urology Open Science
|
May 9, 2022
Learning Curve Analysis for Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section Scientific Working Group
Carl J Wijburg, Gerjon Hannink, Charlotte T J Michels, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 19, 2006
IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI
Emile N J T van Lin, Jurgen J Fütterer, Stijn W T P J Heijmink, et al.
Page
of 44